MYOM1 and myopathy: Thus, we generated an MYOM1−/− hESCs (H9) cell line with CRISPR/Cas9 system, which can be continuously subcultured, and myocytes differentiated from it provide a useful model to study biological functions of MYOM1 and the pathological mechanisms underlying MYOM1‐related myopathies.